This compound is a nitro-substituted quinazoline derivative featuring a chloro-fluoroaniline moiety. It is primarily utilized as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1449430-45-8
4-[(4-Chloro-3-fluorophenyl)amino]-6-nitroquinazolin-7-ol
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for drug synthesis
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for kinase inhibitors
6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol
pharmaceutical intermediate for afatinib impurities
7-fluoro-2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one
pharmaceutical intermediate
1-(1,1-Dimethylethyl) 2-ethyl (2S)-5-oxo-1,2-pyrrolidinedicarboxylate
Pharmaceutical intermediate for peptide synthesis
1-Boc-D-Pyroglutamic acid ethyl ester
Pharmaceutical intermediate
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
impurity reference standard for afatinib
4-(3-chloro-4-fluoroanilino)-6-nitroquinazolin-7-ol
ODEICIIOTUWISY-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])O)Cl)F
—